Allianz Asset Management’s Elanco Animal Health ELAN Stock Holding History

Allianz Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.3M	Sell	296,510 -172,536	-37%	-$3.99M	0.01%	1233
2026 Q1	$11.2M	Buy	469,046 +11,383	+2%	+$278K	0.01%	821
2025 Q4	$10.4M	Buy	457,663 +14,491	+3%	+$315K	0.01%	839
2025 Q3	$8.93M	Buy	443,172 +8,632	+2%	+$145K	0.01%	890
2025 Q2	$6.21M	Sell	434,540 -597,800	-58%	-$6.99M	0.01%	1001
2025 Q1	$10.8M	Sell	1,032,340 -317,192	-24%	-$3.59M	0.01%	785
2024 Q4	$16.3M	Sell	1,349,532 -63,778	-5%	-$835K	0.02%	597
2024 Q3	$20.8M	Buy	1,413,310 +316,155	+29%	+$4.41M	0.03%	533
2024 Q2	$15.8M	Buy	1,097,155 +367,873	+50%	+$5.88M	0.02%	568
2024 Q1	$11.9M	Sell	729,282 -33,456	-4%	-$523K	0.02%	616
2023 Q4	$11.4M	Sell	762,738 -302,316	-28%	-$3.42M	0.02%	652
2023 Q3	$12M	Sell	1,065,054 -3,499	-0.3%	-$40.6K	0.02%	659
2023 Q2	$10.7M	Sell	1,068,553 -24,094	-2%	-$224K	0.02%	631
2023 Q1	$10.3M	Buy	1,092,647 +508	+0%	+$5.99K	0.02%	686
2022 Q4	$13.3M	Hold	1,092,139	–	–	0.03%	593
2022 Q3	$13.6M	Sell	1,092,139 -17,132	-2%	-$299K	0.03%	573
2022 Q2	$21.8M	Buy	1,109,271 +22,676	+2%	+$537K	0.02%	651
2022 Q1	$28.3M	Sell	1,086,595 -14,832	-1%	-$395K	0.02%	629
2021 Q4	$31.3M	Buy	1,101,427 +190,114	+21%	+$5.91M	0.02%	620
2021 Q3	$29.1M	Buy	911,313 +302,351	+50%	+$10.1M	0.02%	597
2021 Q2	$21.1M	Buy	608,962 +60,258	+11%	+$1.99M	0.02%	620
2021 Q1	$16.2M	Buy	548,704 +82,063	+18%	+$2.52M	0.02%	679
2020 Q4	$14.3M	Sell	466,641 -322,702	-41%	-$9.85M	0.01%	730
2020 Q3	$22M	Sell	789,343 -628,212	-44%	-$15.9M	0.03%	537
2020 Q2	$30.4M	Buy	1,417,555 +120,175	+9%	+$2.65M	0.04%	474
2020 Q1	$29M	Sell	1,297,380 -191,611	-13%	-$5.25M	0.04%	436
2019 Q4	$43.9M	Buy	1,488,991 +55,798	+4%	+$1.52M	0.04%	475
2019 Q3	$38.1M	Buy	1,433,193 +308,536	+27%	+$9.26M	0.04%	523
2019 Q2	$38M	Buy	1,124,657 +398,305	+55%	+$12.9M	0.04%	534
2019 Q1	$23.3M	Buy	+726,352	New	+$22.4M	0.02%	698

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Allianz Asset Management's ELAN Position: Q2 2026 in Review

Allianz Asset Management reduced its Elanco Animal Health (ELAN) stake by 37% in Q2 2026, selling an estimated $3.99M and leaving 296,510 shares worth $7.3M. The position accounts for 0.01% of the portfolio, ranked #1233.

Allianz Asset Management first reported a position in ELAN in Q1 2019 and has held it in 30 quarters since. The position peaked at $43.9M in Q4 2019. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Allianz Asset Management held 296,510 shares of Elanco Animal Health worth $7.3M as of Q2 2026.
Allianz Asset Management sold 172,536 Elanco Animal Health shares in Q2 2026, an estimated $3.99M.
Elanco Animal Health made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1233 holding.
Allianz Asset Management first reported a position in Elanco Animal Health in Q1 2019 and has held it in 30 quarters since.
Allianz Asset Management's Elanco Animal Health position peaked at $43.9M in Q4 2019.
523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.